Vertigo
182 results
101 - 182
Intratympanic corticosteroids for Ménière’s disease- Lifestyle and dietary interventions for Ménière’s disease
Neurological examination - Intratympanic corticosteroids for sudden sensorineural hearing loss
- Fibromyalgia
- Migraine
- Hypoglycaemia in the absence of diabetes in adults
- Falls of the elderly
- Phosphodiesterase III inhibitors for heart failure
- Chronic otitis media
- Idiopathic sudden sensorineural hearing loss
- Vestibular rehabilitation for unilateral peripheral vestibular dysfunction
- Nausea and vomiting
- Intratympanic gentamicin for Ménière’s disease
A tailored web-based system of managing BPPV is more effective than a generic video- Peripheral facial paralysis
- Positive pressure therapy for Ménière’s disease
- Corticosteroids for the treatment of vestibular neuritis
- Pharmacological interventions for acute attacks of vestibular migraine
- Aural toilet (ear cleaning) for chronic suppurative otitis media
- Antiepileptic drugs for preventing seizures in people with brain tumors
- Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults
- Intratympanic steroids for Ménière's disease or syndrome: Cochrane systematic review
- Impaired vision
- Ménière's disease
- Special issues in long-term care of elderly persons in assisted living facilities
- Multiple sclerosis (MS)
- Irrigation of the external auditory canal
- Surgery for Ménière's disease
- Steroids for idiopathic sudden sensorineural hearing loss: Cochrane systematic review
- Antivirals for idiopathic sudden sensorineural hearing loss: Cochrane systematic review
- Whiplash injury
- Clobazam add‐on therapy for drug‐resistant epilepsy
- Acute otitis media in adults
- Diving medicine
- Pharmacological agents for the prevention of vestibular migraine
- Pharmacologic interventions for treating phantom limb pain
- Sodium channel blockers for neuroprotection in multiple sclerosis
- Systemic pharmacological interventions for Ménière’s disease
- Angioplasty versus stenting for subclavian artery stenosis
- Minimal and mild traumatic brain injury
- Vestibular rehabilitation for unilateral peripheral vestibular dysfunction: Cochrane systematic review
- Cannabinoids for fibromyalgia
- Restriction of salt, caffeine and alcohol intake for the treatment of Ménière's disease or syndrome
- Gamma‐hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses
- Uncommon infections of the central nervous system
- Brain injury and skull fracture
- Tricyclic drugs for depression in children and adolescents
- Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus)
- Botulinum toxin for subacute/chronic neck pain: Cochrane systematic review
- COVID-19 and other coronavirus infections
- Musculoskeletal pain
- Drugs commonly causing poisonings
- Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis
- Dopamine agonists for preventing future miscarriage in women with idiopathic hyperprolactinemia and recurrent miscarriage history
- Acne
- Baclofen for alcohol use disorder
- Dysphagia
- Lacosamide add‐on therapy for focal epilepsy
- Exercise for acutely hospitalised older medical patients
- Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder
- Oral sumatriptan for acute migraine: Cochrane systematic review
- Meditation for the primary and secondary prevention of cardiovascular disease
- Chloral hydrate as a sedating agent for neurodiagnostic procedures in children
- Gastro-oesophageal reflux disease
- Parkinson's disease
- ADHD